Santarus Inc (SNTS)

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)

September 17 - News - Comments

Santarus, Inc. (SNTS), Nuance Communications Inc. (NUAN), Baidu.com, Inc. (ADR) (BIDU): Here’s What This $17 Billion Money Manager Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

September 16 - News - Comments

Santarus, Inc. (SNTS), Pharmacyclics, Inc. (PCYC), Ariad Pharmaceuticals, Inc. (ARIA): Should You Jump on This Biotech After Profit-Taking?

After a truly remarkable 20-month 650% gain, shares of Santarus, Inc. (NASDAQ:SNTS) have fallen by more than 20% since its all-time high in early August......(read more)

September 13 - News - Comments

PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?

Should PDL BioPharma Inc. (NASDAQ:PDLI) investors track the following data? In the eyes of many market players, hedge funds are seen as overrated, old......(read more)

September 3 - News - Comments

Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......(read more)

August 30 - News - Comments

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)

August 30 - News - Comments

Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?

Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in......(read more)

August 28 - News - Comments

What Hedge Funds Think About VIVUS, Inc. (VVUS)

Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics......(read more)

August 22 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ): Have These 3 Biotechs Reached A Peak?

On Tuesday, several of biotechnology’s hottest names announced earnings. Despite strong results, the market appears to have grown accustomed to perfection......(read more)

August 12 - News - Comments

Santarus, Inc. (SNTS), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ): Three Earning Catalysts That Could Push This Biotech Even Higher

Santarus, Inc. (NASDAQ:SNTS) has traded higher by 250% over the last year, and much of those gains have been created after the company’s last two quarterly......(read more)

July 24 - News - Comments

Santarus, Inc. (SNTS), Cytec Industries Inc (CYT), TD Ameritrade Holding Corp. (AMTD): Four Noteworthy Upgrades on Monday

Stocks get upgraded every day, but some are more impactful and meaningful than others, which is why I’m looking at those that may have the most meaning......(read more)

July 15 - News - Comments

2 to Buy & 1 to Sell After Earnings on Monday: Stratasys, Ltd. (SSYS), Santarus, Inc. (SNTS), Myriad Genetics, Inc. (MYGN)

Monday was a somewhat slow day in terms of companies reporting earnings; however like all days during earnings season, opportunity still presented itself......(read more)

March 5 - News - Comments

Posts Tagged ‘Santarus Inc (SNTS)’

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Santarus, Inc. (SNTS), Nuance Communications Inc. (NUAN), Baidu.com, Inc. (ADR) (BIDU): Here’s What This $17 Billion Money Manager Has Been Buying

Santarus, Inc. (SNTS), Pharmacyclics, Inc. (PCYC), Ariad Pharmaceuticals, Inc. (ARIA): Should You Jump on This Biotech After Profit-Taking?

PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?

Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?

What Hedge Funds Think About VIVUS, Inc. (VVUS)

Regeneron Pharmaceuticals Inc (REGN), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ): Have These 3 Biotechs Reached A Peak?

Santarus, Inc. (SNTS), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ): Three Earning Catalysts That Could Push This Biotech Even Higher

Santarus, Inc. (SNTS), Cytec Industries Inc (CYT), TD Ameritrade Holding Corp. (AMTD): Four Noteworthy Upgrades on Monday

XPO Logistics Inc (XPO), Restoration Hardware Holdings Inc (RH): Top Value Stocks for the Next Six Months

Santarus, Inc. (SNTS), Pacira Pharmaceuticals Inc (PCRX): Make Money in These Growing Pharma Stocks the Easy Way

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Santarus, Inc. (SNTS): Insiders Are Buying, Should You?

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Santarus, Inc. (SNTS) Is a Real Gas!

Lululemon Athletica inc. (LULU), Noble Corporation (NE) & How Hedge Funds Have Bought In..Big

Correcting the Process of Overreaction in the Market: Bank of America Corp (BAC), Seagate Technology PLC (STX)

3 Horrendous Health-Care Stocks This Week: Impax Laboratories Inc (IPXL), Depomed Inc (DEPO), AngioDynamics, Inc. (ANGO)

2 to Buy & 1 to Sell After Earnings on Monday: Stratasys, Ltd. (SSYS), Santarus, Inc. (SNTS), Myriad Genetics, Inc. (MYGN)